Episode 107.0 – Angioedema

Prompted by the recent CAMEO trial publication on icatibant, we dive into angioedema with a focus on airway management.

July 24th, 2017 Download Leave a Comment Tags: , , ,

Show Notes

Take Home Points

  1. Airway management is paramount, expect a challenging intubation and consider controlling the airway early
  2. When controlling the airway, consider an awake approach and fiberoptics if available. Always be prepared for the can’t intubate, can’t oxygenate scenario with a double set up.
  3. If the patient has urticaria and pruritus, the process is likely histamine mediated and will respond to typical anaphylaxis treatment
  4. Finally, observe the patient for progression of swelling and don’t forget to stop the inciting medication

Read More

Core EM: Angioedema

EMCrit: Podcast 145 – Awake Intubation Lecture from SMACC

ERCast: Angioedema

REBEL EM: Icatibant Doesn’t Improve Outcomes in ACE-I Induced Angioedema

The SGEM: Icatibant Bites the Dust – For ACE-I Induced Angioedema

Leave a Reply

Your email address will not be published. Required fields are marked *